Jebsen Group, a marketing and distribution company, yesterday forecast a doubling of its revenue to 16.5 billion yuan (US$2.6 billion) in China by 2015 through adjusting business structure and increasing investment.
The company has won the franchise for a Hong Kong-based traditional Chinese medicine brand and will introduce the products to the Chinese mainland market soon. In the first half of this year, Jebsen's revenue reached 6.2 billion yuan, 40 percent higher than the same period of last year. Company executives attributed the strong growth to a China's fast-growing economy.
